The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl (S)-6-Bromo-4-(2-(2,2,2-trifluoroacetamido)benzamido)spiro[chromane-2,4'-piperidine]-1'-carboxylate ID: ALA4483789
PubChem CID: 155540569
Max Phase: Preclinical
Molecular Formula: C25H25BrF3N3O5
Molecular Weight: 584.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)N1CCC2(CC1)C[C@H](NC(=O)c1ccccc1NC(=O)C(F)(F)F)c1cc(Br)ccc1O2
Standard InChI: InChI=1S/C25H25BrF3N3O5/c1-2-36-23(35)32-11-9-24(10-12-32)14-19(17-13-15(26)7-8-20(17)37-24)30-21(33)16-5-3-4-6-18(16)31-22(34)25(27,28)29/h3-8,13,19H,2,9-12,14H2,1H3,(H,30,33)(H,31,34)/t19-/m0/s1
Standard InChI Key: MGHNUCURWILBOX-IBGZPJMESA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
17.4625 -28.1546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4538 -28.9715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1546 -29.3838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8685 -28.9836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8737 -28.1646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1685 -27.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7517 -28.5615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4680 -27.3350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7587 -26.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0438 -28.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0447 -27.3288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3358 -26.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6256 -27.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6323 -28.1565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3418 -28.5595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5759 -29.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5660 -30.2218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2931 -28.9978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0004 -29.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7657 -26.1000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4779 -25.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4828 -24.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1868 -26.1070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4952 -23.2357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7770 -23.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7768 -24.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2045 -23.6515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1955 -24.4683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9161 -26.9274 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
21.7120 -29.0134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8999 -24.8826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6109 -24.4798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6175 -23.6626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3153 -24.8941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3087 -25.7112 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.0262 -24.4912 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.0200 -25.2999 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
10 7 1 0
7 1 1 0
1 8 1 0
8 9 1 0
9 11 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
9 20 1 1
20 21 1 0
21 22 1 0
21 23 2 0
22 28 2 0
27 24 2 0
24 25 1 0
25 26 2 0
26 22 1 0
27 28 1 0
13 29 1 0
19 30 1 0
28 31 1 0
31 32 1 0
32 33 2 0
32 34 1 0
34 35 1 0
34 36 1 0
34 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 584.39Molecular Weight (Monoisotopic): 583.0930AlogP: 5.19#Rotatable Bonds: 4Polar Surface Area: 96.97Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.43CX Basic pKa: ┄CX LogP: 4.50CX LogD: 4.50Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.52Np Likeness Score: -1.21
References 1. Kazmierski WM, Xia B, Miller J, De la Rosa M, Favre D, Dunham RM, Washio Y, Zhu Z, Wang F, Mebrahtu M, Deng H, Basilla J, Wang L, Evindar G, Fan L, Olszewski A, Prabhu N, Davie C, Messer JA, Samano V.. (2020) DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors., 63 (7): [PMID:32073266 ] [10.1021/acs.jmedchem.9b01799 ]